Flywire CEO Details Efficiency Improvements and AI Integration in Specialty Payment Markets French Mother and Partner Detained in Portugal After Abandoned Children Incident Powell Confirms He Will Step Down as Fed Chair at Term End Remain on Board DJI Engages Independent Auditor in Bid to Counter US Ban Threat Micron Reaches New Milestone Dicks Earnings and Paxton Triumphs Over Cornyn Morning Market Overview Rupee Opens 35 Paise Higher at 9534 Against US Dollar Amid Improved Risk Sentiment and RBI Support XXII Q1 2026 Earnings Massive EPS Miss Amid Continued Transition MTRN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains 234 GMAB Q1 2026 Earnings EPS Falls Short of Estimates as Stock Eases Lower AKBA Q1 2026 Earnings EPS Misses Estimates Amid Operational Developments Kingstone Companies KINS Q1 2026 Earnings WiderThanExpected Loss Pressures Shares RKT Q1 2026 Earnings EPS Surpasses Estimates by 256 Amid Challenging Market Acushnet Holdings GOLF Edges Higher Amid Steady Golf Demand and Consolidation Patterns EXG Holds Steady Near 941 as Support and Resistance Levels Define Range Jade Biosciences Inc JBIO Faces Headwinds Shares Slide 533 as Key Support Levels Are Tested HealthStream HSTM Posts Modest Gain as Shares Test Key Resistance Levels Sanara MedTech SMTI Gains 175 as Stock Tests Key Resistance Level SP 500 Edges Higher as Technology Rally Powers Gains Despite Energy Drag VZ Q1 2026 Earnings EPS Beat on Strong Wireless Execution ACV Auctions ACVA Inches Higher as Buyers Test Key Resistance Zone AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower CPS Q1 2026 Earnings Earnings Miss Estimates Significantly as EPS Falls Short Red Rock Resorts Inc RRR Q1 2026 Earnings EPS Beats Estimates Amid Solid Operations XELLL Q1 2026 Earnings Marginal EPS Miss Amid Stable Utility Operations Boqii Q4 2022 Earnings Significant EPS Beat Amidst Challenging Environment CART Q1 2026 Earnings EPS Misses Estimates Amid Challenging Operating Environment PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline